CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
ConditionCardiac Amyloidosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWake Forest University Health Sciences
About this trial
Exercise training in patients with heart failure and preserved ejection fraction (HFpEF) has been associated with an improvement in cardiorespiratory fitness and quality of life.
Eligibility criteria
Qualifiers
Age > 18
New York Heart Association (NYHA) Class I-III Heart Failure
Able to Exercise
On stable treatment for their cardiac amyloidosis or under active surveillance
Disqualifiers
Inability to provide informed consent
Inability to commit to in-person supervised exercise sessions for three one-hour sessions a week for 12 weeks
NYHA Class IV Heart Failure
Pulmonary disease requiring home oxygen
Trial design
Treatments tested in this trial
- • Cardiac Rehabilitation
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov